Skip to content

Explore the publication

Imaging & AI

All stories

Imaging & AI

Tempus Announces FDA Clearance for ECG-MR, an AI Tool Flagging Possible Undiagnosed Mitral Regurgitation

Tempus says its ECG software for flagging possible undiagnosed mitral regurgitation is cleared, but the announcement gives no accuracy figures, launch date, or reimbursement details that imaging teams and health systems would need to plan.

Read the story

Molecular Medicine

ECG-Free Cardiac Gating From Routine FDG PET Works in Danish Study

A feasibility study found heartbeat signals in most routine FDG PET scans without ECG leads, but ejection fraction limits of agreement were too wide for clinical interchange. Longitudinal testing in patients on chemotherapy has not been done.

October 15, 2026